Subscribe to RSS
DOI: 10.1055/s-2008-1032042
A Practical Synthetic Route to Benzofuro[2,3-b]pyridine and Trifluoromethyl-α-carbolines
Publication History
Publication Date:
16 January 2008 (online)
Abstract
In situ generated benzofuran-2-amine reacts with 1,3-CCC-dielectrophiles, such as CF3-containing β-diketones, 3-formylchromone, methyl-2,4-dioxopentanoate and pentafluorobenzaldehyde, and the reaction leads to the formation of benzofuro[2,3-b]pyridine ring system. By using a similar approach 4-trifluoromethyl-α-carbolines were synthesized starting from indole-2-amine.
Key words
furanamine - indoleamine - pyridine - annulation - electrophilic aromatic substitution
-
1a
Kovtunenko VO. Drug Methods Acting on the Central Nervous System [in Ukrainian] Perun; Kiev: 1997. p.373 -
1b
Silverman RB. The Organic Chemistry of Drug Design, and Drug Action 2nd ed.: Elsevier/Academic Press; New York: 2004. p.617 -
2a
Kleemann A.Engel J.Kutscher B.Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications Thieme; Stuttgart: 2001. -
2b
Ismail FMD. J. Fluorine Chem. 2002, 118: 27 -
3a
Venkat RG,Qi L,Pierce M,Robbins PB,Sahasrabudhe SR, andSelliah R. inventors; Int. Patent WO2007076085. ; Chem. Abstr. 2007, 147, 143456 -
3b
Arakawa H,Monden Y,Nakatsuru Y, andKodera T. inventors; Int. Patent WO2003080077. ; Chem. Abstr. 2003, 139, 286323 -
3c
Burstein HJ.Overmoyer B.Gelman R.Silverman P.Savoie J.Clarke K.Dumadag L.Younger J.Ivy P.Winer EP. Invest. New Drugs 2007, 25: 161 -
4a
Yan H.Mizutani TC.Nomura N.Takakura T.Kitamura Y.Miura H.Nishizawa M.Tatsumi M.Yamamoto N.Sugiura W. Antiviral Chem. Chemother. 2005, 16: 363 -
4b
Li X.Vince R. Bioorg. Med. Chem. 2006, 14: 2942 -
4c
Zhao G.Wang C.Liu C.Lou H. Mini-Rev. Med. Chem. 2007, 7: 707 -
5a
Gelbard HA,Maggirwar SB,Dewhurst S, andSchifitto GP. inventors; Int. Patent WO2007076372. ; Chem. Abstr. 2007, 147, 134456 -
5b
Mellman I, andJiang A. inventors; Int. Patent WO2007075911. ; Chem. Abstr. 2007, 147, 134427 -
6a
Stubbs MC.Armstrong SA. Curr. Drug Targets 2007, 8: 703 -
6b
Shenoy S.Vasania VS.Gopal M.Mehta A. Toxicol. Appl. Pharmacol. 2007, 222: 80 -
6c
Seedhouse CH.Hunter HM.Lloyd-Lewis B.Massip A.-M.Pallis M.Carter GI.Grundy M.Shang S.Russell NH. Leukemia 2006, 20: 2130 -
7a
Joseph J,Meijer L, andLiger F. inventors; Fr. Patent FR2876377. ; Chem. Abstr. 2006, 144, 390900 -
7b
Sennhenn P,Mantoulidis A,Treu M,Tontsch-Grunt U,Spevak W,McConnell D,Schoop A,Brueckner R,Jacobi A,Guertler U,Schnapp G,Klein C,Himmelsbach F,Pautsch A,Betzemeier B,Herfurth L,Mack J,Wiedenmayer D,Bader G, andReiser U. inventors; Int. Patent WO2006131552. ; Chem. Abstr. 2006, 146, 62695 -
7c
Das S,Brown JW,Dong Q,Gong X,Kaldor SW,Liu Y,Paraselli BR,Scorah N,Stafford JA, andWallace MB. inventors; Int. Patent W02007044779. Chem. Abstr. 2007, 146, 441771 - 8
Fong TM,Erondu NE,Macneil DJ,Mcintyre JH, andVan der Ploeg LHT. inventors; Int. Patent WO2004110368. ; Chem. Abstr. 2004, 142, 69181 -
9a
Voigt B.Meijer L.Lozach O.Schaechtele C.Totzke F.Hilgeroth A. Bioorg. Med. Chem. Lett. 2005, 15: 823 -
9b
Xie Y,Zhang G,Wang X,Gray NS, andLiu Y. inventors; Int. Patent WO2007021795. ; Chem. Abstr. 2007, 146, 274386 - 10
Brachwitz K.Hilgeroth A. Bioorg. Med. Chem. Lett. 2002, 12: 411 - 11
Resnati G. Tetrahedron 1993, 49: 9385 -
12a
Mueller U,Connell R,Goldmann S,Gruetzmann R,Beuck M,Bischoff H,Denzer D,Domdey-Bette A, andWohlfeil S. inventors; Eur. Patent EP705831. ; Chem. Abstr. 1996, 125, 58487 -
12b
Gruetzmann R,Mueller U,Bischoff H, andZaiss S. inventors; Int. Patent WO2001097787. ; Chem. Abstr. 2001, 136, 64132 -
13a
Volochnyuk DM.Pushechnikov AO.Krotko DG.Sibgatulin DA.Kovalyova SA.Tolmachev AA. Synthesis 2003, 1531 -
13b
Volochnyuk DM.Kostyuk AN.Sibgatulin DA.Chernega AN. Tetrahedron 2005, 61: 2839 -
13c
Iaroshenko VO.Volochnyuk DM.Wang Y.Vovk MV.Boiko VJ.Rusanov EB.Groth UM.Tolmachev AO. Synthesis 2007, 3309 - 14
Glenn RW,Lim M,Gardlik JM,Jones SD,Murphy BP, andRees CW. inventors; US Patent US2005193504. ; Chem. Abstr. 2005, 143, 292010 - 15
Cruz F.Quijano L.Gomez-Garibay F.Rios T. J. Nat. Prod. 1990, 53: 543 -
16a
Pschorr R.Hoppe G. Ber. Dtsch. Chem. Ges. 1910, 43: 2543 -
16b
Matsumoto T.Yoshida D.Tomita H. Agric. Biol. Chem. 1981, 45: 2031 -
16c
Sagitullin RS.Mel’nikova TV.Kost AN.Snegirev VF.Frenkel EN. Khim. Geterotsikl. Soedin. 1973, 8: 1043 -
16d
Portnov YN,Golubeva GA, andKost AN. inventors; SU Patent SU331060. ; Chem. Abstr. 1972, 77, 19720307 -
16e
Kebrle J.Hoffmann K. Helv. Chim. Acta 1956, 39: 116 -
17a
Pfister JR.Wyman WE. Synthesis 1983, 38 -
17b
Capson TL.Poulter CD. Tetrahedron Lett. 1984, 25: 3515 -
17c
Wang X.-C.Chai L.-Q.Wang M.-G.Quan Z.-Q.Li Z. Synth. Commun. 2006, 36: 645 -
17d
Hu Y.-H.Xiang JS.Di-Grandi MJ.Du X.Ipek M.Laakso LM.Li J.Li W.Rush TS.Schmid J.Skotnicki JS. Bioorg. Med. Chem. 2005, 13: 6629 -
20a
Kost AN.Men’shikov VV.Sagitullin RS. Zh. Org. Khim. 1976, 12: 2234 -
20b
Sadovoy AV.Golubev GA.Nasakin OE. Chem. Heterocycl. Compd. (Engl. Transl.) 2001, 37: 1145 -
20c
Muller U,Eckenberg P,Grutzmann R,Bischoff H,Denzer D,Wohlfeil S,Lohmer S,Nielsch U, andKolkhof P. inventors; Eur. Patent EP799828. ; Chem. Abstr. 1997, 127, 678930 -
21a
Gowravaram S. Aldrichimica Acta 1996, 29: 15 -
21b
Ghosh T.Bandyopadhyay C. J. Heterocycl. Chem. 2006, 43: 1431 -
21c
Quiroga J.Mejia D.Insuasty B.Abonia R.Nogueras M.Sanchez A.Cobo J.Low JN. J. Heterocycl. Chem. 2002, 39: 51 -
21d
Ghosh CK.Ray A.Patra A. J. Heterocycl. Chem. 2001, 38: 1459 -
22a
Jiang JB.Roberts J. J. Heterocycl. Chem. 1985, 22: 159 -
22b
Jiang JB, andIsaacson D. inventors; US Patent US4656274. ; Chem. Abstr. 1987, 127, 318979 - 24 Pento J. T., Li P.-K., Brueggemeier R. W., Hackett J.; Int. Patent WO2006119148, 2006; Chem. Abstr. 2006, 145, 489214
-
26a
Muthian S,Mnich SJ,Burgos LAC, andNaiman BM. inventors; Int. Patent WO2007039797. ; Chem. Abstr. 2007, 146, 375738 -
26b
Nunes JJ,Milne J,Bemis J,Xie R,Vu CB,Ng PY,Disch JS,Salzmann T, andArmistead D. inventors; Int. Patent WO2007019346. ; Chem. Abstr. 2007, 146, 274349 -
26c
Taltavull MJ,Pages S, andLuis M. inventors; Int. Patent WO2007017078. ; Chem. Abstr. 2007, 146, 229376
References and Notes
2-Methyl-4-(trifluoromethyl)benzofuro[2,3- b ]pyridine (5a): colorless solid (1.13 g, 90%); mp 115-117 °C; R f = 0.65 (EtOAc-hexane, 1:2). 1H NMR (400 MHz, DMSO-d 6): δ = 2.68 (s, 3 H), 7.50 (t, 3 J HH = 8.0 Hz, 1 H), 7.66 (t, 3 J HH = 8.0 Hz, 1 H), 7.73 (s, 1 H), 7.83 (d, 3 J HH = 8.0 Hz, 1 H), 7.99 (d, 3 J HH = 8.0 Hz, 1 H). 13C NMR (100.5 MHz, DMSO-d 6): δ = 24.4, 109.8, 112.7, 115.5, 119.7, 123.4, 123.7 (1 J CF = 275 Hz), 124.7, 126.7, 129.9 (2 J CF = 35 Hz), 154.5, 158.1, 163.1. 19F NMR (376.2 MHz, DMSO-d 6): δ = -63.5. MS: m/z (%) = 242 (14) [M+ + 1], 241 (100) [M+], 210 (37), 182 (41). Anal. Calcd for C13H8F3NO: C, 62.16; H, 3.21; N, 5.58. Found: C, 62.18; H, 3.20; N, 5.57.
19General Procedure for the Synthesis of Furo[2,3- b ]pyridines 5, 9, 11, and benzofuro[2,3- b ]quinoline 13: To a boiling solution of AcOH (250 mL) and H2O (10 mL; temperature in the oil bath was about 135 °), a mixture of a dielectrophile (5 mmol) and 2-isocyanatobenzofuran (1.99 g, 12.5 mmol) in absolute DMF (50 mL) was dropped very slowly through the condenser. After the addition was completed the mixture was refluxed for further 3 h. After evaporation of the solvent, the residue was subjected to column chromatography over silica gel, or recrystallized from appropriate solvent.
237,8,9,10-Tetrafluorobenzofuro[2,3- b ]quinoline (13): colorless solid (1.05 g, 72%); mp 235-237 °C (i-PrOH). 1H NMR (400 MHz, DMSO-d 6): δ = 7.55 (t, 3 J HH = 8.0 Hz, 1 H), 7.74 (t, 3 J HH = 8.0 Hz, 1 H), 7.81 (d, 3 J HH = 8.0 Hz, 1 H), 8.40 (d, 3 J HH = 8.0 Hz, 1 H), 9.35 (s, 1 H). MS: m/z (%) = 292 (17) [M+ + 1], 291 (100) [M+], 262 (10), 145 (10). Anal. Calcd for C15H5F4NO: C, 61.87; H, 1.73; N, 4.81. Found: C, 61.85; H, 1.74; N, 4.82.
254-(Difluoromethyl)-2-methylbenzofuro[2,3- b ]pyridine (14a): colorless solid (0.99 g, 85%); mp 112-113 °C; R f = 0.5 (EtOAc-hexane, 1:2). 1H NMR (400 MHz, CDCl3): δ = 2.72 (s, 3 H), 7.04 (t, 2 J HF = 56 Hz, 1 H), 7.31 (s, 1 H), 7.39 (t, 3 J HH = 8.0 Hz, 1 H), 7.53 (t, 3 J HH = 8.0 Hz, 1 H), 7.63 (d, 3 J HH = 8.0 Hz, 1 H), 8.01 (d, 3 J HH = 8.0 Hz, 1 H). 13C NMR (100.5 MHz, CDCl3): δ = 24.5, 110.8, 112.4 (1 J CF = 240 Hz), 113.1, 115.5, 120.9, 123.4, 124.3, 128.6, 136.8 (2 J CF = 26 Hz), 154.6, 157.0, 163.4. 19F NMR (376.2 MHz, DMSO-d 6): δ = -115.3 (d, 2 J HF = 56 Hz, 2 F). MS: m/z (%) = 234 (15) [M+ + 1], 233 (100) [M+], 182 (16). Anal. Calcd for C13H9F2NO: C, 66.95; H, 3.89; N, 6.01. Found: C, 66.94; H, 3.89; N, 6.02.